Prospective Trial of Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Moderately Injured Patients

Abstract

The safety and efficacy of low-molecular-weight heparin (LMWH) was compared with those of conventional unfractionated heparin (UH) in preventing deep venous thrombosis (DVT) in trauma patients with moderate injuries in a prospective double-blind, randomized trial at a level I trauma center. After informed consent, trauma patients meeting inclusion criteria (age > 45 or requiring > 2 days' bedrest) received LMWH or UH twice daily in a double-blind, randomized trial. Patients were excluded if they had severe brain injuries or bleeding injuries not accessible to hemostatic control (eg, severe visceral contusions). Clinical examination and weekly venous duplex ultrasound evaluations were performed to identify DVT. One hundred four patients were randomized, 53 to receive UH and 51 to receive LMWH; 32 UH and 34 LMWH patients completed the study (mean injury severity score [ISS] = 12). There were no significant differences between groups with regard to age, sex, ISS, mechanism of injury, or doses of drug given. Outcome measures such as length of stay in the surgical intensive care unit and hospital days were similar. There were two patients with DVT in the UH group, none in the LMWH group (p = 0.493 by Fisher's exact test). This was not a statistically significant difference. There were five major bleeding complications in each group. The incidence of DVT in injured patients receiving prophylaxis appears to be quite low if individuals such as those with severe head injury or visceral contusions are excluded. LMWH is not clearly beneficial when compared with UH in this moderate-risk trauma population.

Get full access to this article

View all access options for this article.

References

1. Shackford SR , Davis JW , Hollingsworth-Fidlund P , et al: Venous thromboembolism in patients with major trauma. Am J Surg 159:365-369, 1992.

2. Kudsk KA , Fabian TC , Baum S , et al: Silent deep vein thrombosis in immobilized multiple trauma patients. Am J Surg 158:515-519, 1989.

3. Green D , Lee MY , Ito VY , et al: Fixed vs adjusted dose heparin in the prophylaxis of thromboembolism in spinal cord injury. JAMA 260:1255-1258, 1988.

4. Powers PJ , Gent M , Jay RM , et al: A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 149:771-774, 1989.

5. Hull RD , Raskob GE , Gent M , et al: Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 263:2313-2317, 1990.

6. Berry RE , Hill SL , Ruiz AJ , et al: Deep venous thrombosis in the trauma patient (abstract). J Trauma 31:1023-1023, 1991.

7. Burns GA , Cohn SM , Frumento RJ , et al: Prospective ultrasound evaluation of venous thrombosis in highrisk trauma patients. J Trauma 35:405-408, 1993.

8. Green D , Lee MY , Lim AC , et al: Prevention of thromboembolism after spinal cord injury using lowmolecular-weight heparin. Ann Intern Med 113:571-574, 1990.

9. Hull RD , Raskob GE , Pineo GF , et al: Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 326:975-982, 1992.

10.

10. The European Fraxiparin Study (EFS) Group : Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 75:1058-1063, 1988.

11.

11. Turpie AG , Levine MN , Hirsh J , et al: A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 315:925-929, 1986.

12.

12. Geerts WH , Jay RM , Code KI , et al: A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701-707, 1996.

13.

13. Knudson MM , Morabito D , Paiement GD , et al: Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 41:446-459, 1996.